Mifepristone decreases nicotine intake in dependent and non-dependent adult rats
Journal of Psychopharmacology · 2024
DOI: 10.1177/02698811241230255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Psychopharmacology, 2024. Verfasst von Ranjithkumar Chellian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Florida, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Tobacco Use Disorder, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Background
Addiction to tobacco and nicotine products has adverse health effects and afflicts more than a billion people worldwide. Therefore, there is an urgent need for new treatments to reduce tobacco and nicotine use. Glucocorticoid receptor blockade shows promise as a novel treatment for drug abuse and stress-related disorders.
Aim
These studies aim to investigate whether glucocorticoid receptor blockade with mifepristone diminishes the reinforcing properties of nicotine in rats with intermittent or daily long access to nicotine.
Methods
The rats self-administered 0.06 mg/kg/inf of nicotine for 6 h per day, with either intermittent or daily access for 4 weeks before treatment with mifepristone. Daily nicotine self-administration models regular smoking, while intermittent nicotine self-administration models occasional smoking. To determine whether the rats were dependent, they were treated with the nicotinic acetylcholine receptor antagonist mecamylamine, and somatic signs were recorded.
Results
The rats with intermittent access to nicotine had a higher level of nicotine intake per session than those with daily access but only the rats with daily access to nicotine showed signs of physical dependence. Furthermore, mecamylamine increased nicotine intake during the first hour of access in rats with daily access but not in those with intermittent access. Mifepristone decreased total nicotine intake in rats with intermittent and daily access to nicotine. Moreover, mifepristone decreased the distance traveled and rearing in the open field test and operant responding for food pellets.
Conclusion
These findings indicate that mifepristone decreases nicotine intake but this effect may be partially attributed to the sedative effects of mifepristone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, University of Florida, Gainesville, FL, USA.
ORCID-Profile: Ranjithkumar Chellian, Adriaan W Bruijnzeel
Förderung
- NIDA NIH HHS
- National Institute on Drug Abuse
Zitieren
APA
Chellian, R., Behnood-Rod, A., & Bruijnzeel, A. W. (2024). Mifepristone decreases nicotine intake in dependent and non-dependent adult rats. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241230255
Vancouver
Chellian R, Behnood-Rod A, Bruijnzeel AW. Mifepristone decreases nicotine intake in dependent and non-dependent adult rats. Journal of Psychopharmacology. 2024. doi:10.1177/02698811241230255
BibTeX
@article{Chellian2024,
author = {Chellian, Ranjithkumar and Behnood-Rod, Azin and Bruijnzeel, Adriaan W},
title = {Mifepristone decreases nicotine intake in dependent and non-dependent adult rats},
journal = {Journal of Psychopharmacology},
year = {2024},
doi = {10.1177/02698811241230255}
}
EUVIMED